{"name":"XSpray Microparticles","slug":"xspray-microparticles","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Tasigna","genericName":"Tasigna","slug":"tasigna","indication":"Chronic Myelocytic Leukemia Accelerated Phase","status":"marketed"}]}],"pipeline":[{"name":"Tasigna","genericName":"Tasigna","slug":"tasigna","phase":"marketed","mechanism":"Ferrochelatase, mitochondrial, Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma, Serine/threonine-protein kinase MRCK beta","indications":["Chronic Myelocytic Leukemia Accelerated Phase","Chronic phase chronic myeloid leukemia","Philadelphia Chromosome Positive Chronic Myelocytic Leukemia"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxONmpQUldWQXg4YTdlaFJxZ1ZKSHVqbEktejVHVC1kWVMwS3lFSjVzdG5DR3ZyTTYyYWQtWUxRYlhzWGhSZFZQTDY0VkRsdW54eFd2RjU2R210aFFrdXRsaFBna01ZWkpXajZ3QlZtaUZTYTdZYmhDSDAwTnd3SjVvLUZvWGQ?oc=5","date":"2026-04-05","type":"pipeline","source":"marketscreener.com","summary":"Xspray Pharma AB: Shareholders Board Members Managers and Company Profile | SE0028355099 - marketscreener.com","headline":"Xspray Pharma AB: Shareholders Board Members Managers and Company Profile | SE0028355099","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}